Preventing Measles in Immunosuppressed Cancer and Hematopoietic Cell Transplantation Patients: A Position Statement by the American Society for Transplantation and Cellular Therapy

Steven A. Pergam, Janet A. Englund, Mini Kamboj, Hayley A. Gans, Jo Anne H. Young, Joshua A. Hill, Bipin Savani, Roy F. Chemaly, Sanjeet S. Dadwal, Jan Storek, Jeffery Duchin, Paul A. Carpenter

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations

Abstract

Until recently, measles exposures were relatively rare and so, consequently, were an afterthought for cancer patients and/or blood and marrow transplant recipients and their providers. Declines in measles herd immunity have reached critical levels in many communities throughout the United States due to increasing vaccine hesitancy, so that community-based outbreaks have occurred. The reemergence of measles as a clinical disease has raised serious concerns among immunocompromised patients and those who work within the cancer and hematopoietic cell transplantation (HCT) community. Since live attenuated vaccines, such as measles, mumps, and rubella (MMR), are contraindicated in immunocompromised patients, and with no approved antiviral therapies for measles, community exposures in these patients can lead to life-threatening infection. The lack of data regarding measles prevention in this population poses a number of clinical dilemmas. Herein specialists in Infectious Diseases and HCT/cellular therapy endorsed by the American Society of Transplant and Cellular Therapy address frequently asked questions about measles in these high-risk cancer patients and HCT recipients and provide expert opinions based on the limited available data.

Original languageEnglish (US)
Pages (from-to)e321-e330
JournalBiology of Blood and Marrow Transplantation
Volume25
Issue number11
DOIs
StatePublished - Nov 2019

Bibliographical note

Funding Information:
Financial disclosure: The authors have nothing to disclose.

Keywords

  • Hematopoietic cell transplantation
  • MMR
  • Measles
  • Outbreak
  • Vaccination

Fingerprint Dive into the research topics of 'Preventing Measles in Immunosuppressed Cancer and Hematopoietic Cell Transplantation Patients: A Position Statement by the American Society for Transplantation and Cellular Therapy'. Together they form a unique fingerprint.

Cite this